Analyst recommendations: Amazon, PepsiCo, Linde, Pfizer, Crowdstrike Holdings...

Every morning, find a selection of analysts' recommendations covering North America. The list only includes companies that have been the subject of a change of opinion or price target, or of a new coverage. It may be updated during the session. This information can be used to shed light on movements in certain stocks or on market sentiment towards a company.

• Air Products & Chemicals: BNP Paribas Exane maintains its Outperform rating and lowers the price target from $338 to $325.
• Albemarle: Deutsche Bank maintains its Hold rating and raises the price target from $60 to $65.
• Amazon: DZ Bank AG Research maintains its Buy rating and lowers the price target from $270 to $240.
• Api Group: Barclays maintains its Overweight rating and raises the price target from $43 to $48.
• Aptiv: Barclays maintains its Equal Weight rating and raises the price target from $55 to $65.
• Crowdstrike Holdings: Citizens maintains its Outperform rating and raises the price target from $400 to $500.
• Dexcom: Barclays maintains its Equal Weight rating and raises the price target from $90 to $93.
• General Motors: Bernstein maintains its Underperform rating and raises the price target from $35 to $36.
• Hyatt Hotels: HSBC maintains its Hold rating and raises the price target from $113 to $116.
• Ingersoll Rand: BNP Paribas Exane maintains its Neutral rating and raises the price target from $67 to $77.
• Linde: DZ Bank AG Research maintains its Buy rating and lowers the price target from $530 to $525.
• Mettler-Toledo International: Wells Fargo maintains its Equal Weight rating and raises the price target from $1125 to $1200.
• Mohawk Industries: Barclays maintains its Equal Weight rating and lowers the price target from $115 to $111.
• PepsiCo: DZ Bank AG Research maintains its Hold rating and lowers the price target from $162 to $146.
• Pfizer: DZ Bank AG Research maintains its Buy rating and lowers the price target from $32 to $31.
• Regeneron Pharmaceuticals: DZ Bank AG Research maintains its Buy rating and lowers the price target from $1010 to $860.
• Schlumberger: Griffin Securities maintains a Neutral rating and lowers the price target from $44 to $38.
• Smurfit Westrock: Stifel maintains its Buy rating and lowers the price target from $67 to $61.60.
• Starbucks: DZ Bank AG Research maintains its Sell rating and lowers the price target from $95 to $76.
• Twilio: HSBC upgrades its rating from Reduce to Hold and raises the price target from $77 to $99.
• United States Steel: Morgan Stanley maintains its Equal Weight rating and raises the price target from $35 to $38.
• Westlake: Barclays maintains its Overweight rating and lowers the price target from $135 to $100.